Covid-19: President of Portugal sponsors a collective photographic project book - Plataforma Media

Covid-19: President of Portugal sponsors a collective photographic project book

After the exhibition, the book. The EverydayCovid project that was born on the social network Instagram to portray everyday life during the Covid-19 pandemic will be published in a book that is already in pre-sale

Today, at the CC11 Gallery, in the Alvalade neighborhood, in Lisbon, the exhibition “Diário de uma Pandemia” opens with works by more than 130 photographers, showing how the days of the Portuguese have been since the arrival of the Covid-19 pandemic . Following, there is also the book “EverydayCovid – Photographic Diaries in a state of emergency”, an edition with the high sponsorship of the President of the Portuguese Republic, Marcelo Rebelo de Sousa.

The photographic project, founded by photojournalists Miguel A. Lopes and Gonçalo Borges Dias in March this year in a visual diary format, featured 119 Portuguese photographers and photojournalists, including eight editors who daily selected photographic records. One of the participants in the initiative, and the only one outside Portugal, is the editor and photojournalist of PLATAFORMA, Gonçalo Lobo Pinheiro.

Every day, since March 16, 2020, hundreds of photographs of events related to Covid-19 have been published, structured in various formats: reportage, documentary, portrait of society and home diaries. “This photographic diary was registered by professionals who, in their majority, are in very precarious work situations”, can be read on the project’s page, which had no financial incentive.

The book can be purchased in pre-order for 29.90 euros.

Este artigo está disponível em: Português 繁體中文

Related posts
SocietyWorld

Boris Johnson and António Guterres discuss increased vaccine production

SocietyWorld

New cases of covid-19 decreased 16% last week

BrazilSociety

Clandestine parties gather more than 10,000 people in São Paulo

SocietyWorld

North Korea tried to hack Pfizer systems

Assine nossa Newsletter